The Global AMR R&D Hub is pleased to announce the launch of the Pipeline Gallery on the Dynamic Dashboard today. It brings together the information gathered and analysed by the WHO and The Pew Charitable Trusts and provides a high-level overview of antibacterial products in clinical development. More information can be found here.
24.06.2024
UICC Virtual Dialogue on AMR & Cancer
How can R&D for novel antimicrobial medicines and a secure access pipeline effectively address AMR? On 24th June, Dr. Lesley Ogilvie, the Hub Secretariat Director took part in the Virtual Dialogue: “Addressing Antimicrobial Resistance for Better Cancer Care – The Important Role of R&D”.